INKT Annual ROE
124.38%
-6850.75%-98.22%
31 December 2023
Summary:
As of January 23, 2025, INKT annual return on equity is 124.38%, with the most recent change of -6850.75% (-98.22%) on December 31, 2023. During the last 3 years, it has risen by +94.24% (+312.67%). INKT annual ROE is now -98.22% below its all-time high of 6975.13%, reached on December 31, 2022.INKT ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
INKT Quarterly ROE
76.05%
-23.73%-23.78%
30 September 2024
Summary:
As of January 23, 2025, INKT quarterly return on equity is 76.05%, with the most recent change of -23.73% (-23.78%) on September 30, 2024. Over the past year, it has dropped by -120.92% (-61.39%). INKT quarterly ROE is now -94.43% below its all-time high of 1364.65%, reached on June 30, 2023.INKT Quarterly ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
INKT ROE Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -98.2% | -61.4% |
| 3 y3 years | +312.7% | +145.0% |
| 5 y5 years | +89.9% | +145.0% |
INKT ROE High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -98.2% | +197.9% | -94.4% | +111.4% |
| 5 y | 5-year | -98.2% | +197.9% | -94.4% | +111.4% |
| alltime | all time | -98.2% | +197.9% | -94.4% | +111.4% |
MiNK Therapeutics ROE History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | 76.05%(-23.8%) |
| June 2024 | - | 99.78%(-25.6%) |
| Mar 2024 | - | 134.04%(-31.9%) |
| Dec 2023 | 124.38%(-98.2%) | 196.97%(-44.4%) |
| Sept 2023 | - | 354.43%(-74.0%) |
| June 2023 | - | 1364.65%(-305.1%) |
| Mar 2023 | - | -665.43%(+122.0%) |
| Dec 2022 | 6975.13% | -299.75%(+77.4%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2022 | - | -168.93%(-127.1%) |
| June 2022 | - | 624.23%(+350.7%) |
| Mar 2022 | - | 138.51%(+77.1%) |
| Dec 2021 | -127.07%(-521.6%) | 78.20%(+94.2%) |
| Sept 2021 | - | 40.27%(+32.7%) |
| June 2021 | - | 30.34%(+43.0%) |
| Mar 2021 | - | 21.21%(+50.7%) |
| Dec 2020 | 30.14%(-54.0%) | 14.07% |
| Dec 2019 | 65.51% | - |
FAQ
- What is MiNK Therapeutics annual return on equity?
- What is the all time high annual ROE for MiNK Therapeutics?
- What is MiNK Therapeutics annual ROE year-on-year change?
- What is MiNK Therapeutics quarterly return on equity?
- What is the all time high quarterly ROE for MiNK Therapeutics?
- What is MiNK Therapeutics quarterly ROE year-on-year change?
What is MiNK Therapeutics annual return on equity?
The current annual ROE of INKT is 124.38%
What is the all time high annual ROE for MiNK Therapeutics?
MiNK Therapeutics all-time high annual return on equity is 6975.13%
What is MiNK Therapeutics annual ROE year-on-year change?
Over the past year, INKT annual return on equity has changed by -6850.75% (-98.22%)
What is MiNK Therapeutics quarterly return on equity?
The current quarterly ROE of INKT is 76.05%
What is the all time high quarterly ROE for MiNK Therapeutics?
MiNK Therapeutics all-time high quarterly return on equity is 1364.65%
What is MiNK Therapeutics quarterly ROE year-on-year change?
Over the past year, INKT quarterly return on equity has changed by -120.92% (-61.39%)